# Qpex Biopharma, Inc. — Form D

Qpex Biopharma, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-16. The offering totals $33.1M, of which $22.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-10-16
- Form: D
- Accession: 0001755902-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $33.1M
- Amount sold: $22.1M
- Remaining: $11.0M
- Investors: 10
- Date of first sale: 2018-10-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-323670

## Issuer

- Name: Qpex Biopharma, Inc.
- CIK: 0001755902
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 6275 Nancy Ridge Drive, SAN DIEGO, CA, 92121
- Phone: 858-774-7361

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Michael N Dudley | Director | San Diego, CA |
| Michael N Dudley | Executive Officer | San Diego, CA |
| Carol N Gallagher | Director | San Diego, CA |
| Terry N Gould | Director | San Diego, CA |
| Douglas N Reed | Director | San Diego, CA |
| Kevin N Li | Director | San Diego, CA |
| Daniel N Burgess | Director | San Diego, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-08-01](https://search.stillhousedata.com/formd/0001755902-19-000001) | D/A | $41.1M | $27.4M |

## More

- [CIK 1755902 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1755902&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001755902-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.